Vaxart, Inc.
VXRT
$0.347
-$0.01-2.80%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 80.72M | 47.40M | 28.70M | 16.76M | 13.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.72M | 47.40M | 28.70M | 16.76M | 13.93M |
| Cost of Revenue | 118.20M | 85.94M | 74.21M | 66.26M | 66.20M |
| Gross Profit | -37.48M | -38.55M | -45.51M | -49.50M | -52.27M |
| SG&A Expenses | 18.03M | 18.61M | 20.78M | 22.20M | 22.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 136.23M | 104.55M | 94.99M | 88.46M | 88.98M |
| Operating Income | -55.51M | -57.16M | -66.29M | -71.70M | -75.05M |
| Income Before Tax | -56.33M | -57.81M | -66.69M | -72.08M | -75.38M |
| Income Tax Expenses | 309.00K | 310.00K | 260.00K | 258.00K | 279.00K |
| Earnings from Continuing Operations | -56.64 | -58.12 | -66.95 | -72.34 | -75.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.64M | -58.12M | -66.95M | -72.34M | -75.66M |
| EBIT | -55.51M | -57.16M | -66.29M | -71.70M | -75.05M |
| EBITDA | -46.60M | -48.24M | -57.44M | -62.76M | -66.26M |
| EPS Basic | -0.25 | -0.27 | -0.35 | -0.42 | -0.47 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.22 | -0.26 | -0.29 |
| EPS Diluted | -0.25 | -0.27 | -0.35 | -0.42 | -0.47 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.22 | -0.26 | -0.29 |
| Average Basic Shares Outstanding | 911.33M | 867.66M | 808.55M | 722.82M | 647.39M |
| Average Diluted Shares Outstanding | 911.33M | 867.66M | 808.55M | 722.82M | 647.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |